Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Highlights
/health-product-policy-and-standards-(hps)/63022.jpg?sfvrsn=e93c78d1_9 "Ministry of Health staff at their office in Port Vila")
/health-product-policy-and-standards-(hps)/who_034416-sm.jpg?sfvrsn=fc08f9ca_4 "WHO_034416 sm")
/health-product-policy-and-standards-(hps)/70820.jpg?sfvrsn=6b0fda4c_1 "70820")
Events
All →
20 – 24 October 2025
Fifty-ninth meeting of the WHO Expert Committee on Specifications for Pharmaceutical Preparations
28 October 2025 09:00 – 10:30 UTC Time
Open session preceding the 58th meeting of the WHO International Working Group for Drug Statistics Methodology
28 – 29 October 2025
58th meeting of the WHO International Working Group for Drug Statistics Methodology
Expert Committees
Advisory groups
Databases
Publications
All →
6 October 2025
Improving access to assistive technology in United Republic of Tanzania (2022-2023): project report
The report summarizes a collaboration between the Ministry of Health of the United Republic of Tanzania, HelpAge Tanzania and the World Health Organization...
3 October 2025
WHO Drug Information - Volume 39, No. 3
The Third issue of volume 39 for 2025 includes:Consultation Documents: Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum) Cefiderocol powder...
23 September 2025
Availability, price and affordability of health technologies for the management of diabetes
The WHO list of priority medical devices for management of cardiovascular diseases and diabetes, https://iris.who.int/handle/10665/341967, describes those...
5 September 2025
The selection and use of essential medicines, 2025: WHO AWaRe (Access, Watch, Reserve) classification...
The AWaRe classification is intended as a tool for monitoring antibiotic use, defining targets and monitoring the impact of stewardship policies and interventions...
Journal articles
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines: Geneva, Switzerland, December 2019
npj Vaccines 5, 52 (2020)
WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71
Vaccine, Volume 38, Issue 32, 6 July 2020, Pages 4917-4923
Best Practices in Dengue Surveillance: A Report from the Asia-Pacific and Americas Dengue Prevention Boards
PLoS neglected tropical diseases vol. 4,11 e890. 16 Nov. 2010
